Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

New research from medical students and faculty members associated with the University of Colorado School of Medicine at ...

Sleep apnea may lead to weight gain by disrupting sleep, affecting hunger hormones, slowing metabolism, and more. Lifestyle ...

Background: The pathogenesis of daytime hypercapnia (PaCO 2 ≥ 45 mm Hg) may be directly linked to the existence of obstructive sleep apnea syndrome ... and apnea-hypopnea index (AHI) values ...

Obstructive Sleep Apnea (OSA) remains a widespread yet under-treated condition, affecting millions globally. Traditional treatments such as CPAP therapy, w | Drug Discovery And Development ...

Standard treatment for breathing problems caused by obstructive ... change in the apnea-hypopnea index, a scale used to measure the breathing reductions or interruptions during sleep (the higher ...

The clinical syndrome of obstructive sleep apnea (OSAS) in children is a distinct, yet somewhat overlapping disorder with the condition that occurs in adults, such that the clinical manifestations ...

The aura6000 system showed a 65% responder rate at 12 months in patients with obstructive sleep apnea, defined as achieving at least a 50% reduction in apnea-hypopnea index. Results from the pivotal ...

top-line data from its OSPREY randomized controlled trial (RCT), evaluating outcomes with the aura6000™ System for the treatment of moderate to severe obstructive sleep apnea (OSA). At 12 months ...

The researchers found that measures of obstructive sleep apnea ... was examined before and after sleep. PSG-derived OSA variables included the apnea-hypopnea index, total arousal index, and ...

As the associations between obstructive sleep apnea (OSA ... The researchers analyzed variables related to sleep apnea such as apnea-hypopnea index (AHI), total arousal index and a Hypoxemia ...